Iii B John Henneman

Affiliations

  • Director at Aprea Therapeutics Inc. (APRE), 2025-06-09
  • at R1 Rcm Inc. (RCM), 2024-11-19
  • Director at Anika Therapeutics Inc. (ANIK), 2024-07-11
  • at Orthofix Medical Inc. (OFIX), 2024-06-20
  • Director at Seaspine Holdings Corp (SPNE), 2023-01-10
  • Director at R1 Rcm Holdco Inc. (NONE), 2022-06-24
  • Chief Administrative Officer at Newlink Genetics Corp ((NLNK)), 2018-10-02
  • Corpvp, Cao at Integra Lifesciences Holdings Corp (IART), 2014-08-26
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
APRE $7.29 6,860 $50,009.40 8,139 2024-03-13 Filing
ANIK $42.86 2,000 $85,720.00 11,310 2021-05-18 Filing
APRE $15.00 5,000 $75,000.00 5,000 2019-10-07 Filing
ACHI $1.80 12,500 $22,500.00 50,000 2016-08-16 Filing
ACHI $1.80 1,500 $2,700.00 37,500 2016-08-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RCM $17.17 50,000 $858,650.00 72,114 2023-08-08 Filing
SPNE $15.00 10,000 $150,000.00 60,458 2020-08-05 Filing
SPNE $14.65 3,407 $49,912.55 54,708 2018-08-29 Filing
SPNE $14.65 2,029 $29,724.85 58,115 2018-08-28 Filing
SPNE $14.72 4,564 $67,182.08 60,144 2018-08-27 Filing